STING1 and cervical squamous intraepithelial neoplasia: This study supports the idea that targeting the cGAS-STING-dependent inflammatory signaling cascade generated as a consequence of CIN, using IL-6 blockers or STING agonists (Decout et al. 2021; Scott 2017), could be a good therapeutic strategy for CIN tumors.